SEC ownership of ALBIREO PHARMA, INC.

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001322505.

Comparable stake leader

PERCEPTIVE ADVISORS LLC

Disclosed value leader

PERCEPTIVE ADVISORS LLC

Comparable rows

0/5

Latest evidence

02 Mar 2023

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 1 signal
Latest parsed ownership date
02 Mar 2023
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0001322505
Issuer location
Boston, MA

Ownership snapshot

Top shareholders of ALBIREO PHARMA, INC. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
PERCEPTIVE ADVISORS LLC
Disclosed value leader
PERCEPTIVE ADVISORS LLC
Comparable rows
0/5
Latest evidence
02 Mar 2023
3/4/5 Highest disclosed value: $84,959,867 5 rows are not safely comparable across share classes.

Quick read

PERCEPTIVE ADVISORS LLC has the largest disclosed position value at $84.96M.

0 of 5 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens PERCEPTIVE ADVISORS LLC's linked filing trail.
Disclosed position value Top 3
PERCEPTIVE ADVISORS LLC $84.96M
Patrick Taylor Horn $541.1K
Martha J. Carter $160K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-5 of 5 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
PERCEPTIVE ADVISORS LLC
3/4/5
10%+ Owner
class O/S missing
$84,959,867
1,939,723 shares
11 Oct 2022
Patrick Taylor Horn
3/4/5
Chief Medical Officer
class O/S missing
$541,149
12,355 shares
22 Oct 2021
Martha J. Carter
3/4/5
Chief Regulatory Officer
class O/S missing
$160,045
3,654 shares
02 Mar 2023
Anne Klibanski
3/4/5
Director
class O/S missing
8,000 shares
24 Jun 2021
Roger Jeffs
3/4/5
Director
class O/S missing
8,000 shares
24 Jun 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 17 Aug 2025.

Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 0 Shares: 0
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 0 0 $0 $0 $0
3-6 0 0 $0 $0 $0
6-9 0 0 $0 $0 $0
9-12 0 0 $0 $0 $0

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-19 of 19 reporting-owner rows connected to ALBIREO PHARMA, INC.. Open a relationship link for the CIK-to-CIK filing trail.

Rows
19
Largest Forms 3/4/5 holder
PERCEPTIVE ADVISORS LLC
Net 12M change
$0
Latest report
02 Mar 2023
Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
PERCEPTIVE ADVISORS LLC 10%+ Owner $84,959,867 Mixed 11 Oct 2022
Patrick Taylor Horn Chief Medical Officer $541,149 Mixed 22 Oct 2021
Martha J. Carter Chief Regulatory Officer $160,045 Mixed 02 Mar 2023
Habib J. Dable Director Mixed 02 Mar 2023
Jason Duncan Chief Legal Officer and GC Mixed 02 Mar 2023
David Chiswell Director Mixed 02 Mar 2023
Michael Gutch Director Mixed 02 Mar 2023
Anne Klibanski Director Mixed 24 Jun 2021
Michelle Graham Chief Human Resources Officer Mixed 02 Mar 2023
Susan Alesina Director Mixed 02 Mar 2023
Roger Jeffs Director Mixed 24 Jun 2021
Davey Scoon Director Mixed 02 Mar 2023
Paul Streck Chief Medical Officer Mixed 02 Mar 2023
Ronald Harold Wilfred Cooper President and CEO, Director Mixed 02 Mar 2023
Jan Mattsson Chief Scientific Officer Mixed 02 Mar 2023
Pamela Stephenson Chief Commercial Officer Mixed 02 Mar 2023
Simon N.r. Harford CFO and Treasurer Mixed 02 Mar 2023
Craig C. Hopkinson Director Mixed 02 Mar 2023
Stephanie Okey Director Mixed 02 Mar 2023

Recent insider transactions for ALBIREO PHARMA, INC.

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
No insider transactions were found in the last 12 months for this issuer.
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .